Status: Not yet recruiting

Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia

A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients with Sarcopenia

Participants needed: 132

Trial details

Phase: Phase 1, Phase 2Age: 60+Biological sex: AllType: InterventionalSponsor: ENCellUpdated: Sep 11, 2026Locations: 1

Eligibility criteria

Natural amenorrhea for 12 months [+18]

1)Those with the following comorbidities confirmed at the time of screening and... [+28]

Status: Recruiting

Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)

A Phase 1b/2a Clinical Trial to Evaluate the Safety and Efficacy of EN001 in Patients with Charcot-Marie-Tooth Disease type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)

Participants needed: 27

Trial details

Phase: Phase 1, Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: ENCellUpdated: May 26, 2026Locations: 3

Eligibility criteria

Individuals who have voluntarily agreed to participate in this clinical trial. [+11]

Those with the following comorbidities confirmed at the time of screening [+30]

Clinical trials

Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia

Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter)